COVID-19 Infection in Peritoneal Dialysis Patients: A Comparative Outcome Study with Patients on Hemodialysis and Patients without Kidney Disease

Basit Öğe Kaydı
dc.contributor.authorKazancioglu, Rumeyza
dc.contributor.authorOzturk, Savas
dc.contributor.authorTurgutalp, Kenan
dc.contributor.authorGursu, Meltem
dc.contributor.authorArici, Mustafa
dc.contributor.authorOruc, Aysegul
dc.contributor.authorAhbap, Elbis
dc.date.accessioned2024-02-23T14:41:18Z
dc.date.available2024-02-23T14:41:18Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractObjectives: There is limited data about coronavirus disease-19 (COVID-19) characteristics and results in peritoneal dialysis (PD) patients. This study aimed to investigate the characteristics and outcomes among PD patients and compare them with matched hemodialysis (HD) patients and a control group without kidney disease. Methods: We included 18 PD patients and consecutive age- and gender-matched 18 HD and 18 patients without kidney disease (control group) registered into the Turkish Society of Nephrology database including 1301 COVID-19 patients. We compared demographic, clinical, radiological, laboratory data, and outcomes namely intensive care unit (ICU) admission, mechanical ventilation, mortality, and composite outcome (death and/or ICU admission). Results: ICU admission, mechanical ventilation, and mortality rates in PD patients (27.8%, 22.2%, and 22.2%, respectively) and the HD group (16.7%, 11.1%, and 16.7%, respectively) were higher than the control group (11.1%, 11.1%, and 5.6%, respectively), but intergroup comparison did not reveal difference. A total of 11 (20.3%) patients had composite outcome (6 PD patients, 3 HD patients, and 2 patients in the control group). In Cox regression analysis, higher age and higher CRP level were related to increased risk of composite outcome. Adjusted rate of composite outcome in PD group was significantly higher than the control group (P =.050). This rate was similar in HD and control groups (P =.30). Conclusions: Combined in-hospital mortality and/or ICU admission of PD patients with COVID-19 was significantly higher than the control patients. There is a need for careful surveillance of PD patients for infection signs and prompt treatment of COVID-19.en_US
dc.identifier.doi10.5152/turkjnephrol.2021.21045
dc.identifier.endpage42en_US
dc.identifier.issn2667-4440
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85126866042en_US
dc.identifier.startpage33en_US
dc.identifier.urihttps://doi.org/10.5152/turkjnephrol.2021.21045
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16793
dc.identifier.volume31en_US
dc.identifier.wosWOS:000768793000012en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal Of Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19en_US
dc.subjectPeritoneal Dialysisen_US
dc.subjectHemodialysisen_US
dc.subjectOutcomeen_US
dc.titleCOVID-19 Infection in Peritoneal Dialysis Patients: A Comparative Outcome Study with Patients on Hemodialysis and Patients without Kidney Diseaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu